News

Fierce Pharma23h
Genentech pays tribute to moms of children with hemophilia A in Hemlibra short film
A new promo for Roche’s blockbuster hemophilia A drug Hemlibra focuses less on those with the genetic bleeding disorder and ...
Hoodline1d
Genentech Invests $700 Million in New North Carolina Facility, Creating 420 Jobs in Holly Springs
Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...
Biopharma giant Roche pledges 420-job factory in fast-growing Wake County town
The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...
NC Biotech3d
Genentech to build $700M fill-finish facility in Holly Springs
Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot ...
Legit.ng on MSN1d
Trump drug price plan could nix investment, warns Roche
President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche ...
Ten-Year APHINITY Data Show Genentech’s Perjeta-based Regimen Reduced the Risk of Death by 17% in HER2-Positive Early-Stage Breast Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), the Breast International Group (BIG), Institut Jules ...
Fierce Pharma2d
Roche spotlights Perjeta's staying power with 10-year breast cancer survival results
Roche’s Herceptin and Perjeta duo is already part of a well-established standard of care in early-stage HER2-positive breast ...
Landing San Francisco biotech manufacturer includes $13.1M in state incentives
More than $13 million in incentives from North Carolina are pledged to a biotech company making a $700 million investment, a ...